I would like to bring an important public health concern to the
attention of all doctors involved in the care of children. A 7 year old
girl presented to our emergency department with an acute life threatening
hypoxic event after swallowing Bindeez toy beads given to her as a
Christmas present. Paramedics found her with a reduced level of
consciousness and she had a respiratory arrest requiring bag and mask
ventilation....
I would like to bring an important public health concern to the
attention of all doctors involved in the care of children. A 7 year old
girl presented to our emergency department with an acute life threatening
hypoxic event after swallowing Bindeez toy beads given to her as a
Christmas present. Paramedics found her with a reduced level of
consciousness and she had a respiratory arrest requiring bag and mask
ventilation. On arrival to hospital, she had critical bradycardia
requiring cardiopulmonary resuscitation. Initial concerns were that she
may have choked on the beads. However, after intubation, fibreoptic
endoscopy to the carina did not visualise any beads. She did not require
high ventilatory pressures and had good chest movement bilaterally. The
child was retrieved by the local PICU team who extubated her less than 24
hours later. She was then able to tell us that, thinking they were sweets,
she had eaten approximately 80 beads, and they had tasted of marzipan.
Toxicology review revealed that the beads that were found in her
mouth at the scene were coated in 1,4- butanediol, which is metabolised to
ã- Hydroxybutyric acid (GHB), a potent sedative and anaesthetic agent.
Bindeez toy beads “Make, Spray and they stay! Magic beads that join
together with water” were internationally recalled after two similar cases
were reported in Australia(1) in November 2007(2). However, they are
still advertised on toy shop websites for purchase in the UK. Trading
standards have been contacted. It is essential that all paediatricians,
emergency department doctors, anaesthetists and general practitioners are
aware of this extremely serious public health hazard. GHB intoxication
from toys should be considered in all children presenting with depressed
level of consciousness.
1.Gunja N, Doyle E, Carpenter K, et al. gamma-Hydroxybutyrate
poisoning from toy beads. Med J Aust. 2007 Nov 19
2. “Bindeez toys recalled over drug concern” The Times 2007 Nov 9
As it emanates from two of the UK’s major craniofacial units it is
disappointing to see the missed opportunity that the paper, ‘Management of
Plagiocephaly’ by Saeed, Wall and Dhariwal presents and it is saddening
that it reiterates previously stated positions without offering anything
new in the debate on cranial remoulding. The paper selectively quotes
previous research, interprets data to support...
As it emanates from two of the UK’s major craniofacial units it is
disappointing to see the missed opportunity that the paper, ‘Management of
Plagiocephaly’ by Saeed, Wall and Dhariwal presents and it is saddening
that it reiterates previously stated positions without offering anything
new in the debate on cranial remoulding. The paper selectively quotes
previous research, interprets data to support a pre-formulated argument
and offers anecdotal evidence from newspaper articles as fact and valid
reference. My European and American colleagues are astounded at the UK
medical community’s attitude on head shape deformities and are open
mouthed when hearing what parents who come to see us have to say about
their doctor’s advice.
My interest is that I manage a clinic in Leeds offering cranial
remoulding (or ‘helmet’) therapy. I take the UK clinical lead for our
organisation on cranial remoulding and treatment is offered privately to
parents simply because they cannot access treatment through their local
hospital.
Sadly, it is not unusual for us to have infants who had perfectly
normal head shapes at birth, present to us with asymmetries of over 20mm
and head widths significantly over 100% of the length (normal is 78%).
These infants have severe head shape deformities and a referral to a CF
unit for reassurance will not resolve the problem, no matter how much it
is dismissed. Prevention is obviously preferred and improved early advice
would prevent many of these deformities but to simply ignore them is
negligent. Many parents of older children, having followed their doctor’s
advice subsequently correspond with me ask for treatment which we are
unable to start as they are now too old to treat. Despite the assertion in
the paper, correction does not spontaneously occur after the sutures have
fused at age 24 months and I’d be really interested to understand the
mechanism by which the authors explain that it will.
Our experience is that if aggressive repositioning is not entered
into at the time of first notice, usually at 8 weeks, the head shape will
not resolve to any great extent and probably will worsen. Advice on head
positioning, “tummy time” and torticollis management should be given at
birth with an emphasis on placing the baby on the back to sleep. If there
is still a significant plagiocephaly by the age of 5 to 6 months when an
infant should be rolling independently and sitting unsupported, then
cranial remoulding treatment should be considered.
The paper identifies that a ‘small number’ of patients were managed
conservatively and spontaneously self corrected. In a peer review paper
published in such a journal, this surely cannot be accepted without
comment. How many were in the study, at what age were they on referral and
end of monitoring, what was the severity of deformity before and after
monitoring and how was this quantified, what advice was given to effect
the changes and were the parents as happy with the result as the authors?
There are glaring deficits in range of quoted research. Where were
the two Graham studies on plagiocephaly and brachycephaly which found a
significant difference in outcomes between repositioning and orthotic
intervention? Where is the discussion on Kordestani; Developmental Issues,
Siatkowski; Visual Field Problems, Balan; Auditory Response Delays,
Clarren; Developmental Concerns, Panchal; Developmental Issues; Plank; 11
of 13 untreated infants showed no improvement or Bialocerkowski's review
of the literature which did a far better job than was attempted here?
Recently published papers exploring the neural development of infants
with plagiocephaly (Kordestani, Collet, Clarren) were mentioned but
glossed past with no comment. Our anecdotal evidence suggests that these
infants may experience some motor or neural delay, but it is beyond our
scope to explore this. Where are the papers from the authors investigating
these issues?
The paper quotes Hutchinson and extrapolates the findings into the
conclusion that head shapes naturally resolve. I would argue that this is
a misreading of the paper which identified that of the infants who had a
skull deformity at 12 months, 46% still have a severe skull deformity at
age 2. So much for natural resolution in these cases! The other 54% don’t
resolve to zero but only cross an arbitrary line which is still a
significant deformity. Hutchinson states that at 24 months, 3% (of an
initial 200 infants) had a severe deformity. This is 1 in 30, so at least
one in each school class, probably with as many as two or three. I would
argue that the lifelong psychosocial implications of this will be of
greater significance than wearing a helmet in a loving protected
environment for a few months in early infancy?
The paper calls for a randomised controlled trial. I fully agree and
as the authors know we have been active in offering our patient data,
either as a historically treated group or for a randomised control trial,
but my invitation has been met with no takers for whatever reason.
The few downsides reported in the paper seem to have been gleaned
from newspaper articles which as we know are a reliable source! These are
contact dermatitis which is usually no more severe than nappy rash, and
pressure sores which can be likened to a simple pressure area from a new
pair of shoes. If correct management is instituted from the start, these
problems are minor and should be put into context rather than being seen
as reasons for not treating. The same should be said for parental payment
if the Trusts are not willing to fund. This treatment is recognised in
many other countries and although it may not be available on the NHS, it
is effective and invariably brings about positive results as evidenced in
the Graham papers which the authors did not incorporate.
Finally, we come to the advice that the major UK CF centres do not
endorse cranial remoulding treatment. In fact, two UK CF centres do offer
provision of an untested type of orthosis without apparent treatment
protocols or quantified outcomes. Eventually, many parents who have tried
these orthoses come to us for verifiable, structured treatment of their
infants.
I would argue that these normal healthy infants have an advice
induced deformity which is being neglected, with information on and access
to treatment being denied for dogmatic reasons which may ultimately have
budgetary rather than clinical origins. I’d also suggest that UK infants
are being damaged by the absence of treatment and may be subject to
additional problems as a result of the advice, which is neither scientific
nor objective, provided in this paper.
Stephen Mottram MBAPO
Clinical Specialist Orthotist and Cranial Remoulding Specialist
We read your paper with interest. Some of the risk factors for
obesity mentioned may not be modifiable and not taking diet into account
may have a confounding effect on risk factors found significant. We would
like to bring following points to your notice:
1. It was interesting to note that though small for gestational age
(SGA) infants showed higher growth quartiles, they had significantly lower
percentage body...
We read your paper with interest. Some of the risk factors for
obesity mentioned may not be modifiable and not taking diet into account
may have a confounding effect on risk factors found significant. We would
like to bring following points to your notice:
1. It was interesting to note that though small for gestational age
(SGA) infants showed higher growth quartiles, they had significantly lower
percentage body fat (PBF) at 3.5y and at 7 years as compared with those
born appropriate for gestational age (AGA), which actually puts them at a
lower risk of being obese in later life. Other studies suggest that SGA
infants grow rapidly in the first 1-2 years of life and this rapid
postnatal growth links them to central and peripheral obesity in childhood
(1).
2. You do not mention the method you used to calculate the hours of
television viewing each day. There may be great variation in the hours of
TV being watched each day which would be, based on memory, purely a guess
work as to how much TV each child watched every day in last 7 years and to
correlate it with a precise measurement such as PBF can be a gross
exaggeration. Further though sedentary life style is modifiable, physical
activity alone may not be effective in reducing body mass index (2).
3. The relative importance of growth in different periods of
childhood linking to later obesity is still unclear. Other data show that
fast-growing infants of normal weight are at increased risk of developing
obesity later in childhood(3, 4). The trajectory to obesity by your own
admission starts in early infancy. It follows that maternal obesity hardly
remains a modifiable risk factor considering that there may be a genetic
element to it and even if it is environmental, there is lack of effective
treatment or preventive strategies at present.
4. Though you acknowledge that diet can potentially confound or
mediate some of the reported findings, not taking dietary intake into
account potentially questions the validity of risk factors found
significant including increased maternal BMI, sedentary lifestyle and
greater watching of TV. Dietary energy intake during infancy determines
infant weight gain and may influence obesity risk during childhood in at
least among formula- and mixed-fed infants (5). The effect of diet cannot
be taken in isolation but has to be considered in context to interpret any
of the above finding into clinical application. Further you have not
mentioned if any dietary data was collected at any time during the study.
References:
1. Ong KK, Ahmed ML, Emmett PM, et al. Association between postnatal
catch-up growth and obesity in childhood: prospective cohort study. BMJ
2000; 320:967–71.
2. Reilly JJ, Kelly L, Montgomery C et al. Physical activity to
prevent obesity in young children: cluster randomised controlled trial.
BMJ 2006; 333:1041.
3. Papadimitriou A, Gousi T, Giannouli O et al. The growth of
children in relation to the timing of obesity development. Obesity 2006;
14:2173-2178.
4. Stettler N, Zemel BS, Kumanyika S et al. Infant Weight Gain and
Childhood Overweight Status in a Multicenter, Cohort Study. Pediatrics
2002; 109:194-199.
5. Ong KK, Emmett PM, Noble S et al. Dietary Energy Intake at the Age
of 4 Months Predicts Postnatal Weight Gain and Childhood Body Mass.
Pediatrics 2006;117: e503-508.
The review on immune thrombocytopenic purpura (ITP) by Thachil and
Hall brings to surface the wide variations in clinical practice associated
with this not so uncommon disorder in childhood.1 The three year extensive
Nordic study on childhood ITP showed gross differences in management
policies across 98 centres in 5 countries. Whereas some centres treated as
many as 89% of children, a few others followed the watch and wait...
The review on immune thrombocytopenic purpura (ITP) by Thachil and
Hall brings to surface the wide variations in clinical practice associated
with this not so uncommon disorder in childhood.1 The three year extensive
Nordic study on childhood ITP showed gross differences in management
policies across 98 centres in 5 countries. Whereas some centres treated as
many as 89% of children, a few others followed the watch and wait policy
and restricted interventions to just 14% of patients.2 A recent clinical
audit at a district hospital in UK to evaluate the management of children
with ITP demonstrated erroneous practices including bone marrow
examination in the absence of true indications, unnecessary use of
corticosteroids and intravenous immunoglobulin (IVIG), inappropriate blood
product transfusion and inadequate documentation in case notes.3
Variations in the management of a well child with severe
thrombocytopenia can be attributed to the lack of an international
consensus statement. The two major guidelines currently in use are those
from the American Society of Hematology (ASH) and British Society for
Haematology (BSH).4 5 It is interesting to note that there are striking
differences between the recommendations from the two societies. The former
still advocates active therapeutic measures to keep the platelet count
above 20 x 109/L. In contrast, the latter advises against treatment based
solely on the platelet count. Thus a well child with severe
thrombocytopenia is likely to receive steroids, IVIG or no specific
treatment, based on which guideline is being followed by the clinician.
The ASH guideline is based on expert opinion and is eleven years old.
In this period, various workers have demonstrated that a well child who
has no troublesome or life threatening bleeds can be safely managed
without specific treatment measures.6 7 The BSH guideline has based its
recommendations on levels of evidence. Despite this, it is unfortunate
that there is a lack of uniformity in the management of ITP among
paediatricians in UK.
The unambiguous and simple flow diagram based treatment plan by
Thachil and Hall seems to be a timely attempt towards standardisation of
management. As the recommendations are in accordance with the national
guideline from BSH, paediatricians should be able to adopt this as a local
guideline, which in turn will help to achieve uniformity in clinical
practice in a child with ITP.
References
1. Thachil J, Hall GW. Is this immune thrombocytopenic purpura? Arch
Dis Child 2008; 93(1) : 76-81.
2. Treutiger I, Rajantie J, Zeller B et al. Does treatment of newly
diagnosed idiopathic thrombocytopenic purpura reduce morbidity? Arch Dis
Child 2007; 92(8) : 704-7.
3. Anoop P, Mirfattahi MB. Management of immune thrombocytopenic
purpura in children : evaluation of our practice. Clinical audit presented
at Burton Hospitals NHS Trust (unpublished); January 2005.
4. George JN, Woolf SH, Raskob JE et al. Idiopathic thrombocytopenic
purpura: a practice guideline developed by explicit methods for the
American Society of Hematology. Blood 1996; 88(1) : 3-40.
5. British Committee for Standards in Haematology General Haematology
Task Force. Guidelines for the investigation and management of idiopathic
thrombocytopenic purpura in adults, children and in pregnancy. Br J
Haematol 2003; 120(4) : 574-96.
6. Bolton-Maggs PH, Dickerhoff R, Vora AJ. The nontreatment of
childhood ITP (or ‘the art of medicine consists of amusing the patient
until nature cures the disease’). Semin Thromb Hemost 2001; 27(3) : 269-
75.
7. Dickerhoff R, von Ruecker A. The clinical course of immune
thrombocytopenic purpura in children who did not receive intravenous
immunoglobulins or sustained prednisone treatment. J Pediatr 2004; 137 :
629-32.
I would like to bring an important public health concern to the attention of all doctors involved in the care of children. A 7 year old girl presented to our emergency department with an acute life threatening hypoxic event after swallowing Bindeez toy beads given to her as a Christmas present. Paramedics found her with a reduced level of consciousness and she had a respiratory arrest requiring bag and mask ventilation....
Dear Editor
As it emanates from two of the UK’s major craniofacial units it is disappointing to see the missed opportunity that the paper, ‘Management of Plagiocephaly’ by Saeed, Wall and Dhariwal presents and it is saddening that it reiterates previously stated positions without offering anything new in the debate on cranial remoulding. The paper selectively quotes previous research, interprets data to support...
We read your paper with interest. Some of the risk factors for obesity mentioned may not be modifiable and not taking diet into account may have a confounding effect on risk factors found significant. We would like to bring following points to your notice:
1. It was interesting to note that though small for gestational age (SGA) infants showed higher growth quartiles, they had significantly lower percentage body...
The review on immune thrombocytopenic purpura (ITP) by Thachil and Hall brings to surface the wide variations in clinical practice associated with this not so uncommon disorder in childhood.1 The three year extensive Nordic study on childhood ITP showed gross differences in management policies across 98 centres in 5 countries. Whereas some centres treated as many as 89% of children, a few others followed the watch and wait...
Pages